Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Cellular and Molecular Medicine|January 11, 2022
MicroRNA-381 in human cancer: Its involvement in tumour biology and clinical applications potentialHuanhuan Sha, Yujie Gan, Feng Xu, et al.Oncology Letters|May 8, 2018
LXR ligands induce apoptosis of EGFR-TKI-resistant human lung cancer cells <i>in vitro</i> by inhibiting Akt-NF-κB activationSiwen Liu, Haixia Cao, Dan Chen, et al.Journal of Cancer|November 16, 2020
In Vitro and in Vivo Efficacy of NBDHEX on Gefitinib-resistant Human Non-small Cell Lung CancerHuanhuan Sha, Shuchen Dong, Chen Yu, et al.Journal of Neuroinflammation|March 22, 2021
Exosomal miR-409-3p secreted from activated mast cells promotes microglial migration, activation and neuroinflammation by targeting Nr4a2 to activate the NF-κB pathwayLiuqing Hu, Linjie Si, Xiaonan Dai, et al.Cell Death & Disease|March 8, 2018
Cytokine-induced killer cells as a feasible adoptive immunotherapy for the treatment of lung cancerDan Chen, Huanhuan Sha, Tianmu Hu, et al.Disease Markers|July 17, 2023
Aldolase A Promotes Colorectal Cancer Progression through Targeting COPS6 and Regulating MAPK Signaling PathwayYa Lu, Yuan Zhang, Xinyue Wang, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 28, 2017
Genome-wide profiling of micro-RNA expression in gefitinib-resistant human lung adenocarcinoma using microarray for the identification of miR-149-5p modulationYong Hu, Xiaobing Qin, Dali Yan, et al.Oncotarget|February 9, 2017
Liver X receptors agonist GW3965 re-sensitizes gefitinib-resistant human non-small cell lung cancer cell to gefitinib treatment by inhibiting NF-κB in vitroYong Hu, Jialan Zang, Haixia Cao, et al.Pageof 3